Extended Data Fig. 1: Clinical stratification of the 1,171 PDAC patients in our entire ‘RJ-cohort’.
From: Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
(a) Kaplan-Meier survival curves comparing overall survival (OS) among patients with different AJCC stages. Patients are stratified into three groups according to AJCC stages. P-value is calculated using the log-rank test. (b) Kaplan-Meier survival curves comparing OS based on margin status. (c) Kaplan-Meier survival curves comparing OS among patients who received adjuvant chemotherapy. (d) Kaplan-Meier survival curves comparing OS among patients grouped by adjuvant chemotherapy status, including gemcitabine-included (Gem), Non-gemcitabine included (Non-Gem), and those who did not receive adjuvant chemotherapy (No). P-values were calculated using the log-rank test, and the hazard ratios (HR) calculated using the univariable Cox regression analysis.
